BIOTRONIK Blog Explore our latest insightful interviews and articles Image Blog Stories Filter and Search Filter by year - Any -20242023202220212020 Search 46 blog articles Image Blog Advancing Cardiac Patient Management Together Digital Health brings opportunities to advance patient care but also new challenges. In addition to a marked increase in data volume in the clinical space and increased patient involvement in care, digital technology’s role in the care space has changed. This also allows enormous opportunities for early detection and preventing clinical problems, particularly for patients with an implanted cardiac device—when data and new digital technologies are optimally managed. Image Blog Women’s History Month: Celebrating the Women Who Helped Shape Cardiology Women’s History Month is the perfect time to celebrate the incredible achievements of the women who have shaped the field of cardiology. Image Blog New German Supply Chain Act Focuses on Human Rights Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations Image Blog Mindfulness Isn’t Just a Buzzword at BIOTRONIK With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health. Image Blog Myth or Fact? Your Device Security Questions Answered While in office as US Vice-President, Dick Cheney had the remote monitoring function of his pacemaker turned off over concerns a malicious hacker could access his device. In 2012, an episode of the TV drama Homeland depicts a faraway terrorist hacking into the fictional US Vice-President’s pacemaker and assassinating him. It may have made for thrilling TV, but is successful malicious hacking of a cardiac device possible in real life? Image Blog “Discussions With My Daughter Gave Me the Sense That Things Could Continue Normally” BIOTRONIK Employees Share Their Experiences as Relatives of Cardiac Patients Image Blog Sport For Pacemaker or Defibrillator Patients – How to Get Started Again? More than 1.7 million cardiac implantable electronic devices are implanted worldwide each year. Young implant wearers in particular have many questions about whether and how their life will change after the procedure. One of the most important ones: whether and to what extent they can practice sports again. Media coverage of the Danish professional soccer player Christian Eriksen, who had an ICD (implantable cardioverter-defibrillator) implanted after collapsing during an international match, has further increased interest in the interaction between cardiovascular diseases and sport. Image Blog Travelling With a Cardiac Implant is “Easier Than Expected” Rolf Opuchlich has been with the BIOTRONIK Quality Team since 1997. In 2020, he received his own device. Despite knowing just about everything there is to know about the defibrillator he now wears, on his first vacation after getting his implant he was still a bit restless. “I was fairly nervous that first time,” says Rolf looking back at his first flight with his ICD after implantation. “Even though I know our devices well and had everything I needed with me.” Image Blog Team Spirit Through Activity: BIOTRONIK Cyclists Hit Major Road Race After Three-Year Hiatus Continuing a company tradition that started a decade ago, BIOTRONIK employees at the company’s headquarters mounted their bicycles in early July to race through Berlin as a team during VeloCity Berlin—an event that sees teams come together for either a 60km race or a 90km race through the German capital. Pagination Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Previous page ‹ Previous Next page Next › Subscribe for our News You must have JavaScript enabled to use this form. Title Select TitleMsMrMXDrProf First name Last name Role Please select your roleHealthcare ProfessionalPatient or RelativeJournalistOther Email Phone Country/Region - Select -AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSarkSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkmenistanTurks & Caicos IslandsTuvaluTürkiyeU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Topic Please select a topicProductsPatientsHealthcare Professionals I prefer to be contacted by Phone Email Message *Fields are mandatory. Latest Press Releases Show all press releases Image BÜLACH, Switzerland Press Release Two-Year BIOPACT Randomized Controlled Trial (RCT) Analysis Demonstrates “Persistent Excellence” for Low-Profile Passeo-18 Lux DCB BIOTRONIK announced the presentation of two-year results from the investigator-initiated BIOPACT RCT by Principal Investigator Dr. Koen Deloose at the Paris Vascular Insights 2023 congress. The randomized controlled non-inferiority trial evaluated the safety and efficacy of the Passeo®-18 Lux® drug-coated balloon (DCB) catheter compared to the In.Pact Admiral DCB (Medtronic), and showed excellent results for both balloons through 24 months. 1 The prospective, multicenter, core-lab adjudicated non-inferiority trial enrolled 302 patients in Austria, Belgium, France and Switzerland with Image AMSTERDAM, The Netherlands Press Release 12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ® Mission drug-eluting stent (DES) compared to Resolute Onyx DES (p<0.0001) in patients at high risk of bleeding receiving short dual antiplatelet therapy (DAPT). Prof. Marco Valgimigli presented the novel data in a late-breaking trial session at the European Society of Cardiology’s (ESC) Congress in Amsterdam. The results were published simultaneously in Circulation. BIOFLOW-DAPT is a prospective, multi-center, international, two-arm randomized controlled clinical study to assess the safety of one Image BERLIN, Germany Press Release First Implant of Amvia Sky in Europe, the World’s First Pacemaker Approved for LBBAP* The first implant in Europe of BIOTRONIK’s latest pacemaker and CRT-P generation was conducted in early August by Prof. Dr. Jan De Pooter at the University Hospital Ghent in Belgium. The patient who received an Amvia Sky dual chamber pacemaker device was a 68-year-old man suffering from paroxysmal AV-block strongly limiting his physical efforts. “The implantation went on straightforward and very smoothly,” commented Prof. De Pooter after the procedure. “LBBAP enables pacing in a very natural, physiological way, benefiting the patient by offering physiological pacing and minimizing the risk for Press Contact Corporate Public Relations & Communications press@biotronik.com +49 (0) 30 68905 1414 Get in contact
Image Blog Advancing Cardiac Patient Management Together Digital Health brings opportunities to advance patient care but also new challenges. In addition to a marked increase in data volume in the clinical space and increased patient involvement in care, digital technology’s role in the care space has changed. This also allows enormous opportunities for early detection and preventing clinical problems, particularly for patients with an implanted cardiac device—when data and new digital technologies are optimally managed.
Image Blog Advancing Cardiac Patient Management Together Digital Health brings opportunities to advance patient care but also new challenges. In addition to a marked increase in data volume in the clinical space and increased patient involvement in care, digital technology’s role in the care space has changed. This also allows enormous opportunities for early detection and preventing clinical problems, particularly for patients with an implanted cardiac device—when data and new digital technologies are optimally managed.
Image Blog Women’s History Month: Celebrating the Women Who Helped Shape Cardiology Women’s History Month is the perfect time to celebrate the incredible achievements of the women who have shaped the field of cardiology.
Image Blog Women’s History Month: Celebrating the Women Who Helped Shape Cardiology Women’s History Month is the perfect time to celebrate the incredible achievements of the women who have shaped the field of cardiology.
Image Blog New German Supply Chain Act Focuses on Human Rights Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations
Image Blog New German Supply Chain Act Focuses on Human Rights Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations
Image Blog Mindfulness Isn’t Just a Buzzword at BIOTRONIK With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health.
Image Blog Mindfulness Isn’t Just a Buzzword at BIOTRONIK With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health.
Image Blog Myth or Fact? Your Device Security Questions Answered While in office as US Vice-President, Dick Cheney had the remote monitoring function of his pacemaker turned off over concerns a malicious hacker could access his device. In 2012, an episode of the TV drama Homeland depicts a faraway terrorist hacking into the fictional US Vice-President’s pacemaker and assassinating him. It may have made for thrilling TV, but is successful malicious hacking of a cardiac device possible in real life?
Image Blog Myth or Fact? Your Device Security Questions Answered While in office as US Vice-President, Dick Cheney had the remote monitoring function of his pacemaker turned off over concerns a malicious hacker could access his device. In 2012, an episode of the TV drama Homeland depicts a faraway terrorist hacking into the fictional US Vice-President’s pacemaker and assassinating him. It may have made for thrilling TV, but is successful malicious hacking of a cardiac device possible in real life?
Image Blog “Discussions With My Daughter Gave Me the Sense That Things Could Continue Normally” BIOTRONIK Employees Share Their Experiences as Relatives of Cardiac Patients
Image Blog “Discussions With My Daughter Gave Me the Sense That Things Could Continue Normally” BIOTRONIK Employees Share Their Experiences as Relatives of Cardiac Patients
Image Blog Sport For Pacemaker or Defibrillator Patients – How to Get Started Again? More than 1.7 million cardiac implantable electronic devices are implanted worldwide each year. Young implant wearers in particular have many questions about whether and how their life will change after the procedure. One of the most important ones: whether and to what extent they can practice sports again. Media coverage of the Danish professional soccer player Christian Eriksen, who had an ICD (implantable cardioverter-defibrillator) implanted after collapsing during an international match, has further increased interest in the interaction between cardiovascular diseases and sport.
Image Blog Sport For Pacemaker or Defibrillator Patients – How to Get Started Again? More than 1.7 million cardiac implantable electronic devices are implanted worldwide each year. Young implant wearers in particular have many questions about whether and how their life will change after the procedure. One of the most important ones: whether and to what extent they can practice sports again. Media coverage of the Danish professional soccer player Christian Eriksen, who had an ICD (implantable cardioverter-defibrillator) implanted after collapsing during an international match, has further increased interest in the interaction between cardiovascular diseases and sport.
Image Blog Travelling With a Cardiac Implant is “Easier Than Expected” Rolf Opuchlich has been with the BIOTRONIK Quality Team since 1997. In 2020, he received his own device. Despite knowing just about everything there is to know about the defibrillator he now wears, on his first vacation after getting his implant he was still a bit restless. “I was fairly nervous that first time,” says Rolf looking back at his first flight with his ICD after implantation. “Even though I know our devices well and had everything I needed with me.”
Image Blog Travelling With a Cardiac Implant is “Easier Than Expected” Rolf Opuchlich has been with the BIOTRONIK Quality Team since 1997. In 2020, he received his own device. Despite knowing just about everything there is to know about the defibrillator he now wears, on his first vacation after getting his implant he was still a bit restless. “I was fairly nervous that first time,” says Rolf looking back at his first flight with his ICD after implantation. “Even though I know our devices well and had everything I needed with me.”
Image Blog Team Spirit Through Activity: BIOTRONIK Cyclists Hit Major Road Race After Three-Year Hiatus Continuing a company tradition that started a decade ago, BIOTRONIK employees at the company’s headquarters mounted their bicycles in early July to race through Berlin as a team during VeloCity Berlin—an event that sees teams come together for either a 60km race or a 90km race through the German capital.
Image Blog Team Spirit Through Activity: BIOTRONIK Cyclists Hit Major Road Race After Three-Year Hiatus Continuing a company tradition that started a decade ago, BIOTRONIK employees at the company’s headquarters mounted their bicycles in early July to race through Berlin as a team during VeloCity Berlin—an event that sees teams come together for either a 60km race or a 90km race through the German capital.
Image BÜLACH, Switzerland Press Release Two-Year BIOPACT Randomized Controlled Trial (RCT) Analysis Demonstrates “Persistent Excellence” for Low-Profile Passeo-18 Lux DCB BIOTRONIK announced the presentation of two-year results from the investigator-initiated BIOPACT RCT by Principal Investigator Dr. Koen Deloose at the Paris Vascular Insights 2023 congress. The randomized controlled non-inferiority trial evaluated the safety and efficacy of the Passeo®-18 Lux® drug-coated balloon (DCB) catheter compared to the In.Pact Admiral DCB (Medtronic), and showed excellent results for both balloons through 24 months. 1 The prospective, multicenter, core-lab adjudicated non-inferiority trial enrolled 302 patients in Austria, Belgium, France and Switzerland with
Image BÜLACH, Switzerland Press Release Two-Year BIOPACT Randomized Controlled Trial (RCT) Analysis Demonstrates “Persistent Excellence” for Low-Profile Passeo-18 Lux DCB BIOTRONIK announced the presentation of two-year results from the investigator-initiated BIOPACT RCT by Principal Investigator Dr. Koen Deloose at the Paris Vascular Insights 2023 congress. The randomized controlled non-inferiority trial evaluated the safety and efficacy of the Passeo®-18 Lux® drug-coated balloon (DCB) catheter compared to the In.Pact Admiral DCB (Medtronic), and showed excellent results for both balloons through 24 months. 1 The prospective, multicenter, core-lab adjudicated non-inferiority trial enrolled 302 patients in Austria, Belgium, France and Switzerland with
Image AMSTERDAM, The Netherlands Press Release 12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ® Mission drug-eluting stent (DES) compared to Resolute Onyx DES (p<0.0001) in patients at high risk of bleeding receiving short dual antiplatelet therapy (DAPT). Prof. Marco Valgimigli presented the novel data in a late-breaking trial session at the European Society of Cardiology’s (ESC) Congress in Amsterdam. The results were published simultaneously in Circulation. BIOFLOW-DAPT is a prospective, multi-center, international, two-arm randomized controlled clinical study to assess the safety of one
Image AMSTERDAM, The Netherlands Press Release 12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ® Mission drug-eluting stent (DES) compared to Resolute Onyx DES (p<0.0001) in patients at high risk of bleeding receiving short dual antiplatelet therapy (DAPT). Prof. Marco Valgimigli presented the novel data in a late-breaking trial session at the European Society of Cardiology’s (ESC) Congress in Amsterdam. The results were published simultaneously in Circulation. BIOFLOW-DAPT is a prospective, multi-center, international, two-arm randomized controlled clinical study to assess the safety of one
Image BERLIN, Germany Press Release First Implant of Amvia Sky in Europe, the World’s First Pacemaker Approved for LBBAP* The first implant in Europe of BIOTRONIK’s latest pacemaker and CRT-P generation was conducted in early August by Prof. Dr. Jan De Pooter at the University Hospital Ghent in Belgium. The patient who received an Amvia Sky dual chamber pacemaker device was a 68-year-old man suffering from paroxysmal AV-block strongly limiting his physical efforts. “The implantation went on straightforward and very smoothly,” commented Prof. De Pooter after the procedure. “LBBAP enables pacing in a very natural, physiological way, benefiting the patient by offering physiological pacing and minimizing the risk for
Image BERLIN, Germany Press Release First Implant of Amvia Sky in Europe, the World’s First Pacemaker Approved for LBBAP* The first implant in Europe of BIOTRONIK’s latest pacemaker and CRT-P generation was conducted in early August by Prof. Dr. Jan De Pooter at the University Hospital Ghent in Belgium. The patient who received an Amvia Sky dual chamber pacemaker device was a 68-year-old man suffering from paroxysmal AV-block strongly limiting his physical efforts. “The implantation went on straightforward and very smoothly,” commented Prof. De Pooter after the procedure. “LBBAP enables pacing in a very natural, physiological way, benefiting the patient by offering physiological pacing and minimizing the risk for